PHL-AMANTADINE 100 MG
AMANTADINE HYDROCHLORIDE : 100 MG · DIN 02238306 · PHARMEL INC
Health Canada status: CANCELLED POST MARKET
What is PHL-AMANTADINE?
PHL-AMANTADINE 100 MG contains AMANTADINE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02238306, held by PHARMEL INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PHL-AMANTADINE used for?
Treatment of Parkinson's Syndrome, drug-induced extrapyramidal reactions, and prophylaxis/symptomatic treatment of respiratory tract infections caused by Influenza A virus strains.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02238306 |
|---|---|
| Brand name | PHL-AMANTADINE |
| Generic / active ingredient | AMANTADINE HYDROCHLORIDE : 100 MG |
| Manufacturer | PHARMEL INC |
| Strength | 100 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04BB01 AMANTADINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2009 |
How is it administered?
Parkinsonism: 100 mg twice daily. Drug-induced extrapyramidal: 100 mg twice daily. Influenza A: Dosage varies by age/risk. Reduce dose in renal impairment and elderly.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-30°C).
How is it supplied?
Capsules: Bottles of 100 and 1000. Syrup: Bottles of 250 mL and 500 mL.
Contraindications
Known hypersensitivity to the drug.
Warnings and precautions
Monitor for congestive heart failure, peripheral edema, and increased seizure activity in patients with epilepsy. Do not discontinue abruptly. May cause CNS effects/blurred vision.
What can be used instead?
Other Canadian products sharing ATC code N04BB01 AMANTADINE. 3 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ODAN-AMANTADINE SYRUP | 10 MG | SYRUP | ODAN LABORATORIES LTD | MARKETED | DIN 02538601 |
| PDP-AMANTADINE HYDROCHLORIDE CAPSULES | 100 MG | CAPSULE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 01990403 |
| PDP-AMANTADINE HYDROCHLORIDE SYRUP | 50 MG / 5 ML | SYRUP | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02022826 |
| DOM-AMANTADINE HYDROCHLORIDE CAPSULES-100MG | 100 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02130963 |
| ENDANTADINE | 100 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02034468 |
| ENDANTADINE CAP 100MG | 100 MG | CAPSULE | DUPONT MERCK PHARMA INC. | CANCELLED POST MARKET | DIN 01919288 |
| MED-AMANTIDINE - CAP 100MG | Strength | Capsule | MEDICAN PHARMA INCORPORATED 203 1120 Victoria St North Kitchener Ontario Canada N2B 3T2 | CANCELLED POST MARKET | DIN 02199289 |
| MYLAN-AMANTADINE | 100 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02139200 |
| PHL-AMANTADINE SYRUP 10MG/ML | 10 MG | SYRUP | PHARMEL INC | CANCELLED POST MARKET | DIN 02262649 |
| PMS-AMANTADINE HYDROCHLORIDE CAPSULES | 100 MG | CAPSULE | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02494140 |
Who else supplies AMANTADINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. AMANTADINE appears in 18 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.